Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BHW Bayerische Heilmittel Wissenschaften GmbH is a German life sciences company headquartered in Munich, specializing in the research, development, and global distribution of pharmaceuticals, medical devices, and science-based food supplements. As a key member of the international Heilmittel Group, the company integrates Bavarian pharmaceutical heritage with modern innovation to serve markets across Europe, North America, and the Middle East. Its commercial portfolio features flagship brands such as Cebedi (synthetic CBD), Silicolgel (gastrointestinal support), and CollaMouv (collagen therapies). BHW operates with GMP-certified manufacturing partners in Germany, Spain, and Switzerland, ensuring high standards of quality and regulatory compliance. The company is recognized for its evidence-based formulations and advanced delivery systems, including Oral Dissolving Film (ODF) technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BHW Bayerische Heilmittel Wissenschaften.